(3-甲酰基-2-甲基-1H-吲哚-1-基)乙酸甲酯 | 431983-71-0

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (3-甲酰基-2-甲基-1H-吲哚-1-基)乙酸甲酯
• 中文别名: (3-甲酰基-2-甲基-吲哚-1-基)-乙酸甲酯
• 英文名称: methyl 2-(3-formyl-2-methyl-1H-indol-1-yl)acetate
• 英文别名: methyl (3-formyl-2-methyl-1H-indol-1-yl)acetate；methyl 2-(3-formyl-2-methylindol-1-yl)acetate
• CAS: 431983-71-0
• 化学式: C₁₃H₁₃NO₃
• mdl: MFCD02909100
• 分子量: 231.251
• InChiKey: GLTOPUVGYLBJTJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.23
• 拓扑面积：
  48.3
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  萘并[2,1-b]呋喃-2-甲酰肼 、 (3-甲酰基-2-甲基-1H-吲哚-1-基)乙酸甲酯 在 溶剂黄146 作用下， 以 乙醇 为溶剂， 反应 2.0h， 以90%的产率得到methyl (E)-2-(2-methyl-3-((2-(naphtho[2,1-b]furan-2-carbonyl)hydrazono)methyl)-1H-indole-1-yl)acetate
  参考文献：
  名称：

  EP3418271

  摘要：

  公开号：

文献信息

• NOVEL INDOLE DERIVATIVE AND ANTI-CANCER COMPOSITION CONTAINING SAME
  申请人：Korea Research Institute of Bioscience and Biotechnology

  公开号：EP3418271A1

  公开（公告）日：2018-12-26

  The present invention relates to: an indole derivative, which is a novel cell mitosis inhibitor; a stereoisomer thereof or a pharmaceutically acceptable salt thereof; a use thereof as a therapeutic agent; a composition containing the same and a treatment method using the composition; and a preparation method therefor. According to the present invention, the indole derivative, the stereoisomer thereof or the pharmaceutically acceptable salt thereof, inhibits the tubulin polymerization during mitosis so as to induce apoptosis, and has an excellent anti-cancer effect also in cancer cells having multiple drug resistance.

  本发明涉及：一种吲哚衍生物，它是一种新型细胞有丝分裂抑制剂；其立体异构体或其药学上可接受的盐；其作为治疗剂的用途；含有其的组合物和使用该组合物的治疗方法；以及其制备方法。根据本发明，吲哚衍生物、其立体异构体或其药学上可接受的盐可抑制有丝分裂过程中的微管蛋白聚合，从而诱导细胞凋亡，对具有多重耐药性的癌细胞也有很好的抗癌效果。
• NOVEL INDOLE DERIVATIVE AND ANTI-CANCER CONPOSITION CONTAINING SAME
  申请人：KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY

  公开号：US20210292306A1

  公开（公告）日：2021-09-23

  The present invention relates to: an indole derivative, which is a novel cell mitosis inhibitor; a stereoisomer thereof or a pharmaceutically acceptable salt thereof; a use thereof as a therapeutic agent; a composition containing the same and a treatment method using the composition; and a preparation method therefor. According to the present invention, the indole derivative, the stereoisomer thereof or the pharmaceutically acceptable salt thereof, inhibits the tubulin polymerization during mitosis so as to induce apoptosis, and has an excellent anti-cancer effect also in cancer cells having multiple drug resistance.
• EP3418271
  申请人：——

  公开号：——

  公开（公告）日：——